NCT02958436View on ClinicalTrials.gov

A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 18, 2017

Study Completion Date

October 3, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

REGN3500

DRUG

Placebo

Trial Locations (1)

Unknown

Site 1, Ghent

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY